Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Source filing unavailable
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $107.95M | — |
| Net Income | $28.66M | — |
| EPS Diluted | $0.78 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
